Synedica Retatrutide 40mg Pen Price: UK Research Guide
If you are searching for the Synedica Retatrutide 40mg pen price, you are likely comparing current research-product pricing, product formats and catalogue options before making a purchasing decision.
The current online catalogue lists a Retatrutide Triple Agonist Injection Pen Kit containing 40mg total at £110. A separate 40mg bulk listing is also available, with the displayed price ranging from £130 to £6,200, depending on the selected quantity.
This guide explains the current catalogue pricing, the difference between the pen and bulk formats, what to check before ordering research material, and the important UK regulatory context surrounding retatrutide.
Current Retatrutide 40mg Pen Price
The current catalogue price for the 40mg Retatrutide Triple Agonist Injection Pen Kit is:
£110
The catalogue describes this product as containing 40mg total and presents it as a research product.
For buyers comparing the available formats, the catalogue currently separates the 40mg pen from the bulk-price listing.
| Product | Listed quantity | Current displayed price |
|---|---|---|
| Retatrutide Triple Agonist Injection Pen Kit | 40mg total | £110 |
| Retatrutide 40mg Bulk Price | 40mg | £130–£6,200 |
Prices can change, so the live product page should always be checked before relying on a displayed price.
Why Search for a 40mg Retatrutide Pen?
The search term “Retatrutide 40mg pen price” is highly specific because it indicates that the person searching is not simply researching retatrutide.
They are looking for information about:
- A specific 40mg product format
- Current pricing
- UK availability or catalogue information
- Product specifications
- Research-use information
- Potential bulk alternatives
- Supplier and documentation information
That makes the keyword particularly relevant for people performing commercial research before viewing a product catalogue.
40mg Pen vs 40mg Bulk Pricing
The catalogue currently contains two distinct 40mg-related options.
40mg Retatrutide Pen
The pen format is currently displayed at £110.
This is listed separately as the Retatrutide Triple Agonist Injection Pen Kit, with 40mg total stated in the product name.
40mg Bulk Price
The separate bulk listing currently displays a range of £130–£6,200.
The difference exists because bulk purchasing can involve different quantity tiers. Therefore, the headline price alone does not tell you the effective per-unit cost at every quantity.
For anyone comparing prices, it is useful to look at:
- Total quantity
- Price per unit
- Product format
- Total stated amount
- Documentation available
- Shipping information
- Research-use restrictions
Retatrutide 40mg Price Comparison
If your main objective is finding the current catalogue price, the simplest comparison is:
40mg pen: £110
40mg bulk listing: £130–£6,200
The pen and bulk listing should not automatically be treated as identical purchasing options because they are presented as separate products in the catalogue.
What Is Retatrutide?
Retatrutide is an investigational compound being studied in clinical research. It is commonly described in scientific literature as a triple agonist, because it acts on three hormone-related receptor pathways.
Research into retatrutide has attracted significant interest because of its activity across GLP-1, GIP and glucagon receptor pathways.
However, research interest should not be confused with regulatory approval.
As of the latest UK information available, retatrutide remains an investigational product rather than an approved UK medicine. The MHRA has stated that retatrutide is in clinical development and has not been approved for UK use.
Is Retatrutide 40mg Approved in the UK?
No.
Retatrutide is still undergoing clinical development and is not an authorised medicine for general UK use.
The MHRA statement reported in 2025 specifically warned that products claiming to contain retatrutide and being sold outside authorised clinical trials may be illegal and potentially dangerous.
For this reason, information about a 40mg retatrutide pen should be understood in the context of research material rather than as a recommendation for personal use.
What Should You Check Before Ordering Research Material?
Price is only one part of evaluating a research product.
Before purchasing, researchers and laboratories should review the available product information and documentation.
1. Product identity
Confirm that the product name and stated quantity match the catalogue listing.
2. Quantity
A 40mg product and a bulk package containing multiple units should not be confused when comparing prices.
3. Documentation
Where applicable, review available laboratory documentation and product information before making a purchasing decision.
4. Storage information
Research materials may have specific storage requirements. Follow the supplier’s documented handling and storage information.
5. Research-use status
Confirm that the product is being supplied for its stated research purpose and understand any restrictions that apply.
6. Current price
Online catalogue prices can change. Always check the current product page rather than relying on an older article, screenshot or search result.
Why the 40mg Price Matters
For commercial researchers, purchasing departments and laboratories, the total listed price is only one consideration.
A better comparison involves the effective cost per unit or quantity.
For example, if a supplier lists several bulk tiers, a larger order may have a different effective unit price than a single-product purchase.
That is why searches such as:
- Retatrutide 40mg price
- Retatrutide 40mg bulk price
- Retatrutide 40mg pen price UK
- Retatrutide research price
- Retatrutide research product UK
can represent different stages of the same purchasing research process.
Current Catalogue Information
The current catalogue also contains other research products alongside the 40mg retatrutide options, including CagriReta and CagriSema formulations. The displayed catalogue currently lists CagriReta at £120 and CagriSema at £80.
These products should be evaluated separately because their stated compositions and product formats differ.
Retatrutide 40mg Pen Price: What Does £110 Represent?
The current catalogue displays £110 for the 40mg Retatrutide Triple Agonist Injection Pen Kit.
That figure represents the displayed catalogue price for that particular product listing. It should not automatically be interpreted as a medical treatment cost, prescription price, monthly healthcare cost or recommended personal-use price.
The product is presented within a research-product catalogue.
Frequently Asked Questions
How much is a Retatrutide 40mg pen?
The current catalogue lists the 40mg Retatrutide Triple Agonist Injection Pen Kit at £110.
What is the current Retatrutide 40mg price in the UK?
The current catalogue displays £110 for the 40mg pen format. A separate bulk listing displays £130–£6,200, depending on quantity.
Is the 40mg pen the same as the bulk product?
They are separate catalogue listings. The pen is listed as a 40mg total Triple Agonist Injection Pen Kit, while the bulk listing uses quantity-based pricing.
Is retatrutide approved for general use in the UK?
No. Retatrutide remains an investigational compound and has not been approved for UK use.
Can I use research retatrutide as a medicine?
Research products should not be presented as approved medicines or substitutes for regulated medical treatment. Retatrutide is not currently an authorised UK medicine.
Does the Retatrutide 40mg price change?
Catalogue prices can change. Check the current product listing for the latest displayed price before making purchasing decisions.
Final Takeaway
For people specifically searching for the Synedica Retatrutide 40mg pen price, the current catalogue figure to know is £110 for the 40mg Triple Agonist Injection Pen Kit.
The catalogue also lists a separate 40mg bulk option from £130 to £6,200, making it useful to compare the individual pen format with quantity-based purchasing options.
Because retatrutide remains investigational and is not approved for general UK use, all product information should be interpreted within the appropriate research-use and regulatory context.
Research-use notice: Product information on this page is provided for research and informational purposes. Retatrutide is not presented as an approved medicine, and this page does not provide medical advice, dosing instructions or recommendations for human or veterinary use.
